June 25, 2022 Comments Off on New patent expiration for Mylan Speciality drug ELESTRIN Posted in: Uncategorized
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared first…
June 25, 2022 Comments Off on New patent expiration for Allergan drug GELNIQUE 3% Posted in: Uncategorized
Annual Drug Patent Expirations for GELNIQUE+3%25 Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…
The post New patent expiration for Allergan drug GELNIQUE 3% appea…